Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267M in stock, CVRs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharmaceuticals to acquire Strongbridge in stock, CVR transaction
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eloxx Pharmaceuticals to acquire Zikani Therapeutics in all-stock transaction
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UPDATE: Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock, GW soars 46% premarket
Jazz Pharmaceuticals Plc said Wednesday it has agreed to acquire GW Pharmaceuticals Plc in a cash-and-stock deal valued at $7.2 billion. Under the terms of the d.....»»
Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock
Jazz Pharmaceuticals Plc said Wednesday it has agreed to acquire GW Pharmaceuticals Plc in a cash-and-stock deal valued at $.....»»
Xeris Pharmaceuticals files to offer 6M shares of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharma stock rallies more than 20% on study results
Xeris Pharmaceuticals Inc. shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a .....»»
Why this King of Prussia biopharma"s stock rose 32% Thursday
Paratek Pharmaceuticals's stock closed up 32% Thursday after the biopharmaceutical company announced it was awarded a five-year contract worth up to $285 million from the federal government. The funds will support the development of the company's a.....»»
Main Line biopharma firm expects $65M from stock sale; shares soar
Marinus Pharmaceuticals Inc. expects to bring in $65 million this week from a public stock offering and concurrent private placement. The proceeds from the stock sales will be used by the Radnor company to advance the preclinical and clinical develop.....»»
Commit To Purchase Xeris Pharmaceuticals At $7.50, Earn 21.2% Annualized Using Options
Stock Options Channel.....»»
Is Xeris Pharmaceuticals, Inc. (XERS) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, t.....»»
Ra Pharma Stock Doubles On $2.5B Buyout Deal With Belgian Biopharma UCB
Ra Pharmaceuticals Inc (NASDAQ: RARX) shares were up 100% Thursday following the announcement of a buyout by Belgian biopharma UCB SA (OTC: UCBJF). read more.....»»
Belgium"s UCB to acquire Ra Pharma in cash deal valued at about $2.5 billion
Belgian biopharma company UCB has agreed to acquire Ra Pharmaceuticals Inc. in a cash deal valued at about $2.5 billion, the companies said Thursday. Ra Pharma shareholders will receive $48 per sha.....»»
Lantheus To Acquire Progenics Pharma In All-Stock Deal
Micro-cap biotech Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) is advancing strongly following an announcement concerning a buyout deal. read more.....»»
Biotech Stock On The Radar: Is Vanda A Buy Ahead Of Its PDUFA Date?
Small-cap biopharma Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has withstood the market-wide sell-off witnessed in early August, thanks to the second-quarter report the company issued July 31. read more.....»»
Commit To Buy Xeris Pharmaceuticals At $10, Earn 40.2% Annualized Using Options
Stock Options Channel.....»»
First Week of August 17th Options Trading For Strongbridge Biopharma (SBBP)
Stock Options Channel.....»»
Strongbridge Biopharma started at buy with $13 stock fair value estimate at Janney
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
66 Stocks Moving In Wednesday"s Mid-Day Session
Gainers Strongbridge Biopharma plc (NASDAQ: SBBP) shares jumped 30.9 percent to $5.30 after it was reported Novo Nordisk will acquire the US and Canadian rights to MACRILEN from the company and acquire 5.2 million shares for $7/share. read more.....»»
Xeris Pharmaceuticals files to sell 5M shares of common stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UMB will buy Heartland Financial in an all-stock deal worth about $2B
UMB Financial agreed to terms for its biggest acquisition yet, an all-stock deal to acquire Heartland Financial USA......»»